Trials / Recruiting
RecruitingNCT07002762
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
Multicentre, Double-blind, Randomized, Placebo-controlled Trial of Clinical Efficacy of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- OMNIFARMA LLC · Industry
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, with the primary objective to assess the efficacy of the use of burdock root extract in patients with asymptomatic hyperuricaemia versus placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Burdock ( Arctium lappa L.) root extract in a form of a nutritional additive | Gastric soluble capsules each containing: 750 mg of burdock ( Arctium lappa L.) root extract in the form of a nutritional additive |
| OTHER | Placebo | Gastric soluble capsules each containing: Maltodextrin, silicon dioxide, calcium stearate, food colourants |
Timeline
- Start date
- 2025-03-12
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
- First posted
- 2025-06-04
- Last updated
- 2025-07-30
Locations
1 site across 1 country: Ukraine
Source: ClinicalTrials.gov record NCT07002762. Inclusion in this directory is not an endorsement.